Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
4.790
+0.140 (3.01%)
At close: Mar 9, 2026, 4:00 PM EDT
4.800
+0.010 (0.21%)
After-hours: Mar 9, 2026, 7:48 PM EDT
Anavex Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| Market Capitalization | 444 | 764 | 482 | 537 | 804 | 1,359 | |
| Market Cap Growth | -37.51% | 58.72% | -10.27% | -33.27% | -40.83% | 396.34% | |
| Enterprise Value | 312 | 663 | 343 | 382 | 651 | 1,202 | |
| Last Close Price | 4.79 | 8.90 | 5.68 | 6.55 | 10.32 | 17.95 | |
| PB Ratio | 3.51 | 8.06 | 4.01 | 3.78 | 5.65 | 9.01 | |
| P/TBV Ratio | 3.51 | 8.06 | 4.01 | 3.78 | 5.65 | 9.01 | |
| Net Debt / Equity Ratio | -1.04 | -1.08 | -1.10 | -1.06 | -1.05 | -1.01 | |
| Quick Ratio | 20.81 | 11.56 | 8.80 | 12.27 | 14.92 | 14.93 | |
| Current Ratio | 20.87 | 11.61 | 8.86 | 12.32 | 14.95 | 14.97 | |
| Return on Equity (ROE) | -33.63% | -43.11% | -32.81% | -33.41% | -32.71% | -42.58% | |
| Return on Assets (ROA) | -21.56% | -26.51% | -21.81% | -21.59% | -18.95% | -23.87% | |
| Return on Capital Employed (ROCE) | -35.00% | -53.50% | -42.10% | -37.40% | -33.40% | -24.80% | |
| Earnings Yield | -9.00% | -6.07% | -8.93% | -8.85% | -5.96% | -2.79% | |
| Buyback Yield / Dilution | -2.61% | -2.18% | -4.61% | -3.74% | -10.18% | -19.95% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.